Cargando…

Antibodies against glutamic acid decarboxylase and indices of insulin resistance and insulin secretion in nondiabetic adults: a cross-sectional study

BACKGROUND: Autoimmunity against insulin-producing beta cells from pancreatic islets is a common phenomenon in type 1 diabetes and latent autoimmune diabetes in adults. Some reports have also related beta-cell autoimmunity to insulin resistance (IR) in type 2 diabetes. However, the extent to which a...

Descripción completa

Detalles Bibliográficos
Autores principales: Mendivil, Carlos O, Toloza, Freddy JK, Ricardo-Silgado, Maria L, Morales-Álvarez, Martha C, Mantilla-Rivas, Jose O, Pinzón-Cortés, Jairo A, Lemus, Hernán N
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428762/
https://www.ncbi.nlm.nih.gov/pubmed/28507444
http://dx.doi.org/10.2147/DMSO.S137216
_version_ 1783235895045914624
author Mendivil, Carlos O
Toloza, Freddy JK
Ricardo-Silgado, Maria L
Morales-Álvarez, Martha C
Mantilla-Rivas, Jose O
Pinzón-Cortés, Jairo A
Lemus, Hernán N
author_facet Mendivil, Carlos O
Toloza, Freddy JK
Ricardo-Silgado, Maria L
Morales-Álvarez, Martha C
Mantilla-Rivas, Jose O
Pinzón-Cortés, Jairo A
Lemus, Hernán N
author_sort Mendivil, Carlos O
collection PubMed
description BACKGROUND: Autoimmunity against insulin-producing beta cells from pancreatic islets is a common phenomenon in type 1 diabetes and latent autoimmune diabetes in adults. Some reports have also related beta-cell autoimmunity to insulin resistance (IR) in type 2 diabetes. However, the extent to which autoimmunity against components of beta cells is present and relates to IR and insulin secretion in nondiabetic adults is uncertain. AIM: To explore the association between antibodies against glutamic acid decarboxylase (GADA), a major antigen from beta cells, and indices of whole-body IR and beta-cell capacity/insulin secretion in adults who do not have diabetes. METHODS: We studied 81 adults of both sexes aged 30–70, without known diabetes or any autoimmune disease. Participants underwent an oral glucose tolerance test (OGTT) with determination of plasma glucose and insulin at 0, 30, 60, 90, and 120 minutes. From these results we calculated indices of insulin resistance (homeostasis model assessment of insulin resistance [HOMA-IR] and incremental area under the insulin curve [iAUCins]) and insulin secretion (corrected insulin response at 30 minutes and HOMA beta-cell%). GADAs were measured in fasting plasma using immunoenzymatic methods. RESULTS: We found an overall prevalence of GADA positivity of 21.3%, without differences by sex and no correlation with age. GADA titers did not change monotonically across quartiles of any of the IR or insulin secretion indices studies. GADA did not correlate linearly with fasting IR expressed as HOMA-IR (Spearman’s r=−0.18, p=0.10) or postabsorptive IR expressed as iAUCins (r=−0.15, p=0.18), but did show a trend toward a negative correlation with insulin secretory capacity expressed by the HOMA-beta cell% index (r=−0.20, p=0.07). Hemoglobin A1c, body mass index, and waist circumference were not associated with GADA titers. CONCLUSION: GADA positivity is frequent and likely related to impaired beta-cell function among adults without known diabetes.
format Online
Article
Text
id pubmed-5428762
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Dove Medical Press
record_format MEDLINE/PubMed
spelling pubmed-54287622017-05-15 Antibodies against glutamic acid decarboxylase and indices of insulin resistance and insulin secretion in nondiabetic adults: a cross-sectional study Mendivil, Carlos O Toloza, Freddy JK Ricardo-Silgado, Maria L Morales-Álvarez, Martha C Mantilla-Rivas, Jose O Pinzón-Cortés, Jairo A Lemus, Hernán N Diabetes Metab Syndr Obes Original Research BACKGROUND: Autoimmunity against insulin-producing beta cells from pancreatic islets is a common phenomenon in type 1 diabetes and latent autoimmune diabetes in adults. Some reports have also related beta-cell autoimmunity to insulin resistance (IR) in type 2 diabetes. However, the extent to which autoimmunity against components of beta cells is present and relates to IR and insulin secretion in nondiabetic adults is uncertain. AIM: To explore the association between antibodies against glutamic acid decarboxylase (GADA), a major antigen from beta cells, and indices of whole-body IR and beta-cell capacity/insulin secretion in adults who do not have diabetes. METHODS: We studied 81 adults of both sexes aged 30–70, without known diabetes or any autoimmune disease. Participants underwent an oral glucose tolerance test (OGTT) with determination of plasma glucose and insulin at 0, 30, 60, 90, and 120 minutes. From these results we calculated indices of insulin resistance (homeostasis model assessment of insulin resistance [HOMA-IR] and incremental area under the insulin curve [iAUCins]) and insulin secretion (corrected insulin response at 30 minutes and HOMA beta-cell%). GADAs were measured in fasting plasma using immunoenzymatic methods. RESULTS: We found an overall prevalence of GADA positivity of 21.3%, without differences by sex and no correlation with age. GADA titers did not change monotonically across quartiles of any of the IR or insulin secretion indices studies. GADA did not correlate linearly with fasting IR expressed as HOMA-IR (Spearman’s r=−0.18, p=0.10) or postabsorptive IR expressed as iAUCins (r=−0.15, p=0.18), but did show a trend toward a negative correlation with insulin secretory capacity expressed by the HOMA-beta cell% index (r=−0.20, p=0.07). Hemoglobin A1c, body mass index, and waist circumference were not associated with GADA titers. CONCLUSION: GADA positivity is frequent and likely related to impaired beta-cell function among adults without known diabetes. Dove Medical Press 2017-05-08 /pmc/articles/PMC5428762/ /pubmed/28507444 http://dx.doi.org/10.2147/DMSO.S137216 Text en © 2017 Mendivil et al. This work is published and licensed by Dove Medical Press Limited The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed.
spellingShingle Original Research
Mendivil, Carlos O
Toloza, Freddy JK
Ricardo-Silgado, Maria L
Morales-Álvarez, Martha C
Mantilla-Rivas, Jose O
Pinzón-Cortés, Jairo A
Lemus, Hernán N
Antibodies against glutamic acid decarboxylase and indices of insulin resistance and insulin secretion in nondiabetic adults: a cross-sectional study
title Antibodies against glutamic acid decarboxylase and indices of insulin resistance and insulin secretion in nondiabetic adults: a cross-sectional study
title_full Antibodies against glutamic acid decarboxylase and indices of insulin resistance and insulin secretion in nondiabetic adults: a cross-sectional study
title_fullStr Antibodies against glutamic acid decarboxylase and indices of insulin resistance and insulin secretion in nondiabetic adults: a cross-sectional study
title_full_unstemmed Antibodies against glutamic acid decarboxylase and indices of insulin resistance and insulin secretion in nondiabetic adults: a cross-sectional study
title_short Antibodies against glutamic acid decarboxylase and indices of insulin resistance and insulin secretion in nondiabetic adults: a cross-sectional study
title_sort antibodies against glutamic acid decarboxylase and indices of insulin resistance and insulin secretion in nondiabetic adults: a cross-sectional study
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5428762/
https://www.ncbi.nlm.nih.gov/pubmed/28507444
http://dx.doi.org/10.2147/DMSO.S137216
work_keys_str_mv AT mendivilcarloso antibodiesagainstglutamicaciddecarboxylaseandindicesofinsulinresistanceandinsulinsecretioninnondiabeticadultsacrosssectionalstudy
AT tolozafreddyjk antibodiesagainstglutamicaciddecarboxylaseandindicesofinsulinresistanceandinsulinsecretioninnondiabeticadultsacrosssectionalstudy
AT ricardosilgadomarial antibodiesagainstglutamicaciddecarboxylaseandindicesofinsulinresistanceandinsulinsecretioninnondiabeticadultsacrosssectionalstudy
AT moralesalvarezmarthac antibodiesagainstglutamicaciddecarboxylaseandindicesofinsulinresistanceandinsulinsecretioninnondiabeticadultsacrosssectionalstudy
AT mantillarivasjoseo antibodiesagainstglutamicaciddecarboxylaseandindicesofinsulinresistanceandinsulinsecretioninnondiabeticadultsacrosssectionalstudy
AT pinzoncortesjairoa antibodiesagainstglutamicaciddecarboxylaseandindicesofinsulinresistanceandinsulinsecretioninnondiabeticadultsacrosssectionalstudy
AT lemushernann antibodiesagainstglutamicaciddecarboxylaseandindicesofinsulinresistanceandinsulinsecretioninnondiabeticadultsacrosssectionalstudy